← Back to Clinical Trials
Recruiting NCT06336122

NCT06336122 OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06336122
Status Recruiting
Phase
Sponsor The University of Texas Medical Branch, Galveston
Condition Diabetes Mellitus, Type 2
Study Type INTERVENTIONAL
Enrollment 76 participants
Start Date 2023-11-20
Primary Completion 2027-03-31

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Peer Coach Training - WeeklyPeer Coach Training - Biweekly

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 76 participants in total. It began in 2023-11-20 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of the peer model are most effective? Peer coaches will undergo peer coach training. * Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting. Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.

Eligibility Criteria

Inclusion Criteria: * Age greater than or equal to 55 years * Resident in Rural Kentucky * Positive Diagnosis of Type 2 Diabetes Mellitus * HbA1c greater than or equal to 7.5% * Passing score on cognitive assessment administered by study personnel * English Speaking Exclusion Criteria: * Age less than 55 years * Not a resident of a Rural Kentucky County * No Type 2 Diabetes Mellitus Diagnosis * HbA1c under 7.5% * Cognitive Impairment * Non-english speaking

Contact & Investigator

Central Contact

Brittany L. Smalls, PhD

✉ blsmalls@utmb.edu

📞 409-772-1011

Principal Investigator

Brittany L. Smalls, PhD

PRINCIPAL INVESTIGATOR

University of Texas Medial Branch

Frequently Asked Questions

Who can join the NCT06336122 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06336122 currently recruiting?

Yes, NCT06336122 is actively recruiting participants. Contact the research team at blsmalls@utmb.edu for enrollment information.

Where is the NCT06336122 trial being conducted?

This trial is being conducted at Bowling Green, United States, Hazard, United States.

Who is sponsoring the NCT06336122 clinical trial?

NCT06336122 is sponsored by The University of Texas Medical Branch, Galveston. The principal investigator is Brittany L. Smalls, PhD at University of Texas Medial Branch. The trial plans to enroll 76 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology